Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-20-052824
Filing Date
2020-04-29
Accepted
2020-04-29 07:47:43
Documents
18
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A hcm-20191231x20fa.htm   iXBRL 20-F/A 107366
2 EX-1.2 hcm-20191231xex1d2.htm EX-1.2 604249
3 EX-2.4 hcm-20191231xex2d4.htm EX-2.4 85598
4 EX-2.5 hcm-20191231xex2d5.htm EX-2.5 96522
5 EX-12.1 hcm-20191231xex12d1.htm EX-12.1 15616
6 EX-12.2 hcm-20191231xex12d2.htm EX-12.2 13271
  Complete submission text file 0001104659-20-052824.txt   1270362

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA hcm-20191231.xsd EX-101.SCH 3187
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hcm-20191231_def.xml EX-101.DEF 17812
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hcm-20191231_lab.xml EX-101.LAB 27904
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hcm-20191231_pre.xml EX-101.PRE 18897
15 EXTRACTED XBRL INSTANCE DOCUMENT hcm-20191231x20fa_htm.xml XML 9377
Mailing Address 48TH FLOOR, CHEUNG KONG CENTER 2 QUEEN'S ROAD CENTRAL HONG KONG K3 00000
Business Address 48TH FLOOR, CHEUNG KONG CENTER 2 QUEEN'S ROAD CENTRAL HONG KONG K3 00000 852-2121-3888
Hutchison China MediTech Ltd (Filer) CIK: 0001648257 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 20-F/A | Act: 34 | File No.: 001-37710 | Film No.: 20827434
SIC: 2834 Pharmaceutical Preparations